AAPL 258.8189 0.2397% MSFT 439.14 -0.0432% NVDA 140.185 -0.025% GOOGL 196.0128 -0.0496% GOOG 197.54 -0.0152% AMZN 227.87 -0.5152% META 603.74 -0.6598% AVGO 245.6915 2.5081% TSLA 452.9125 -2.0264% TSM 204.19 -1.0372% LLY 797.2122 0.1938% V 320.96 0.0967% JPM 242.37 0.0248% UNH 509.62 0.6955% NVO 87.85 0.5494% WMT 92.38 -0.3237% LVMUY 132.91 0.4459% XOM 106.31 -0.0846% LVMHF 664.0 0.9119% MA 536.2159 0.0944%
Last update at 2024-01-23T20:02:01.870719Z
| Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
| Income before tax | -756.40300M | -542.25800M | -120.22700M | -81.61200M | -589.47700M |
| Minority interest | - | - | - | - | - |
| Net income | -749.93600M | -538.47800M | -100.07000M | -469.21900M | -422.21300M |
| Selling general administrative | 4902.09M | 4998.76M | 4657.19M | 4587.34M | 4592.38M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 4803.94M | 5106.49M | 4704.32M | 4726.76M | 4676.35M |
| Reconciled depreciation | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M |
| Ebit | -98.14700M | 72.62M | 47.14M | 139.42M | 83.98M |
| Ebitda | 178.44M | 368.31M | 374.26M | 467.70M | 441.86M |
| Depreciation and amortization | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M |
| Non operating income net other | 148.73M | -8.74000M | 117.00M | 55.69M | -0.55400M |
| Operating income | -98.14700M | 72.62M | 47.14M | 139.42M | 83.98M |
| Other operating expenses | 24190.05M | 24495.64M | 23996.10M | 21788.97M | 21555.58M |
| Interest expense | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M |
| Tax provision | -6.46700M | -3.78000M | -20.15700M | 387.61M | 77.48M |
| Interest income | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M |
| Net interest income | -224.39900M | -191.60100M | -201.38800M | -229.65700M | -227.72800M |
| Extraordinary items | 0.00000M | 0.00000M | 9.16M | 17.05M | 244.74M |
| Non recurring | 371.20M | 229.00M | 29.85M | - | -107.99400M |
| Other items | - | - | - | - | - |
| Income tax expense | -6.46700M | -3.78000M | -20.15700M | 387.61M | 77.48M |
| Total revenue | 24091.90M | 24568.26M | 24043.24M | 21928.39M | 21639.56M |
| Total operating expenses | 4902.09M | 5033.88M | 4657.19M | 4587.34M | 4592.38M |
| Cost of revenue | 19287.96M | 19461.76M | 19338.92M | 17201.63M | 16963.21M |
| Total other income expense net | -658.25600M | -614.87700M | -167.36400M | -221.03400M | -445.72600M |
| Discontinued operations | - | - | 9.16M | 17.05M | 244.74M |
| Net income from continuing ops | -749.93600M | -538.47800M | -100.07000M | -469.21900M | -666.95400M |
| Net income applicable to common shares | -749.93600M | -538.47800M | -90.90900M | -452.17400M | -422.21300M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
| Total assets | 7527.36M | 8529.00M | 9335.40M | 9452.37M | 7591.37M |
| Intangible assets | 250.11M | 291.20M | 340.52M | 359.49M | 448.71M |
| Earning assets | - | - | - | - | - |
| Other current assets | 93.19M | 106.75M | 106.94M | 181.79M | 179.13M |
| Total liab | 8169.14M | 8429.97M | 8720.25M | 8777.84M | 6404.68M |
| Total stockholder equity | -641.77600M | 99.03M | 615.15M | 674.53M | 1186.69M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 724.53M | 780.63M | 642.36M | 37.06M | 727.73M |
| Common stock | 56.63M | 55.75M | 55.14M | 54.72M | 1080.32M |
| Capital stock | 56.63M | 55.75M | 55.14M | 54.72M | 54.02M |
| Retained earnings | -6601.51700M | -5851.58100M | -5313.10300M | -5222.19400M | -4713.24400M |
| Other liab | - | 151.98M | 208.21M | 204.44M | 482.89M |
| Good will | 507.94M | 879.14M | 1108.14M | 1108.14M | 1108.14M |
| Other assets | 63.29M | 106.61M | 139.96M | 157.99M | 624.29M |
| Cash | 157.15M | 39.72M | 160.90M | 218.18M | 144.35M |
| Cash and equivalents | 157.15M | 39.72M | 160.90M | 218.18M | 144.35M |
| Total current liabilities | 2727.88M | 2933.09M | 2602.95M | 2766.46M | 2443.14M |
| Current deferred revenue | - | - | - | 746.32M | 80.71M |
| Net debt | 5662.36M | 5886.38M | 6271.35M | 6087.76M | 3350.41M |
| Short term debt | 508.74M | 581.20M | 523.16M | 499.00M | 16.11M |
| Short long term debt | 6.33M | 5.54M | 6.41M | 8.84M | 16.11M |
| Short long term debt total | 5819.52M | 5926.10M | 6432.25M | 6305.94M | 3494.76M |
| Other stockholder equity | 5917.96M | 5910.30M | 5897.17M | 5890.90M | 4850.67M |
| Property plant equipment | 3404.98M | 3802.70M | 4144.58M | 1215.84M | 1308.51M |
| Total current assets | 3301.05M | 3449.36M | 3595.17M | 3700.64M | 4101.72M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | -1399.82400M | -1071.29900M | -833.50100M | -793.10000M | -370.15200M |
| Short term investments | - | - | - | - | 7.19M |
| Net receivables | 1149.96M | 1343.50M | 1462.44M | 1286.79M | 1788.71M |
| Long term debt | 2925.26M | 2732.99M | 3063.09M | 3077.27M | 3454.59M |
| Inventory | 1900.74M | 1959.39M | 1864.89M | 1921.60M | 1871.94M |
| Accounts payable | 1494.61M | 1571.26M | 1437.42M | 1484.08M | 1618.59M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -14.85200M | -15.43700M | -24.05400M | -48.89800M | -31.05900M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 56.63M | 55.75M | 55.14M | 54.72M | 54.02M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | -6601.51700M | -5851.58100M | -5313.10300M | -5222.19400M | -4713.24400M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 50.92M | 86.54M | 132.03M | 148.33M | 215.21M |
| Deferred long term asset charges | - | - | - | - | 409.08M |
| Non current assets total | 4226.31M | 5079.65M | 5740.23M | 5751.73M | 3489.65M |
| Capital lease obligations | 2887.93M | 3187.57M | 3362.76M | 3219.83M | 24.06M |
| Long term debt total | 2937.84M | 2747.82M | 3063.09M | 3077.27M | 3478.65M |
| Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
| Investments | -104.75900M | -134.07300M | -15.02500M | -86.54200M | 2.59M |
| Change to liabilities | -207.59100M | 207.79M | -35.37200M | -154.23000M | -313.98100M |
| Total cashflows from investing activities | -104.75900M | -134.07300M | -15.02500M | -149.84900M | -198.55200M |
| Net borrowings | 277.29M | -363.79200M | -8.61900M | 600.00M | 803.41M |
| Total cash from financing activities | 274.63M | -366.38000M | -65.24300M | -326.65200M | -540.50400M |
| Change to operating activities | - | 72.92M | 1.98M | -86.40700M | -438.90600M |
| Net income | -749.93600M | -538.47800M | -100.07000M | -469.21900M | -666.95400M |
| Change in cash | 117.43M | -121.18100M | -57.27800M | 73.83M | -302.98100M |
| Begin period cash flow | 39.72M | 160.90M | 218.18M | 144.35M | 447.33M |
| End period cash flow | 157.15M | 39.72M | 160.90M | 218.18M | 144.35M |
| Total cash from operating activities | -52.43900M | 379.27M | 22.99M | 487.02M | -228.66500M |
| Issuance of capital stock | 0.00000M | 0.00000M | 0.05M | 0.00000M | 2.29M |
| Depreciation | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M |
| Other cashflows from investing activities | 110.53M | 86.64M | 284.70M | 63.31M | 660.38M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 5.16M | -97.11200M | 177.26M | 15.14M | -44.64500M |
| Change to account receivables | 151.61M | 54.09M | -182.40400M | 486.56M | -75.84400M |
| Sale purchase of stock | 0.00000M | 0.00000M | 0.05M | - | 2.29M |
| Other cashflows from financing activities | 552.57M | 319.66M | 993.24M | 604.45M | -102.42800M |
| Change to netincome | 294.74M | 245.40M | -174.69600M | 261.88M | 513.88M |
| Capital expenditures | 247.69M | 220.71M | 224.94M | 214.39M | 244.69M |
| Change receivables | 151.61M | 54.09M | -182.40400M | 486.56M | -75.84400M |
| Cash flows other operating | -572.93900M | -326.56900M | 5.99M | -450.61500M | -665.95400M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | 117.43M | -121.18100M | -69.39900M | 34.36M | -302.98100M |
| Change in working capital | -100.47800M | 169.12M | -38.52900M | 323.24M | -433.47000M |
| Stock based compensation | 11.54M | 13.05M | 13.00M | 16.09M | 12.12M |
| Other non cash items | 502.15M | 446.60M | -167.90500M | -97.26300M | 406.12M |
| Free cash flow | -300.12400M | 158.56M | -201.95100M | 272.63M | -473.35400M |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RAD Rite Aid Corporation |
- -% | - | - | - | 0.0099 | 3.77 | 0.27 | -17.1507 |
| WBA Walgreens Boots Alliance Inc |
0.42 4.62% | 9.62 | - | 5.40 | 0.11 | 1.14 | 0.33 | -4.3066 |
| RADLY Raia Drogasil SA ADR |
0.12 3.86% | 3.23 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBHF Alibaba Health Information Technology Limited |
0.005 1.14% | 0.45 | 50.80 | 29.59 | 0.30 | 3.62 | 1.58 | 34.83 |
| ALBBY Alibaba Health Information Technology Limited |
0.04 0.50% | 8.98 | 48.10 | 30.30 | 0.29 | 3.70 | 1.58 | 34.83 |
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
1200 Intrepid Avenue, Philadelphia, PA, United States
| Name | Title | Year Born |
|---|---|---|
| Ms. Heyward Rutledge Donigan B.A. | Pres, CEO & Director | 1961 |
| Mr. Matthew C. Schroeder | CFO & Exec. VP | 1970 |
| Mr. Paul D. Gilbert | Exec. VP, Gen. Counsel & Corp. Sec. | 1967 |
| Mr. Brian T. Hoover | Chief Accounting Officer & Sr. VP | 1965 |
| Mr. Justin L. Mennen | Exec. VP and Chief Technology & Digital Officer | 1981 |
| Byron Purcell | VP of Investor Relations & Treasurer | NA |
| Joy Errico Seusing | Sr. VP & Chief Communications Officer | NA |
| Mr. Frank G. Vitrano | Chief Strategic Bus. Devel. Officer | 1955 |
| Ms. Jessica Kazmaier | Exec. VP & Chief HR Officer | 1978 |
| Mr. Christopher S. Hall | Sr. VP of Pharmacy Services | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...